191 related articles for article (PubMed ID: 37623967)
1. Therapeutic Potential of Engineered Virus-like Particles of Parvovirus B19.
Sánchez-Moguel I; Montiel C; Bustos-Jaimes I
Pathogens; 2023 Aug; 12(8):. PubMed ID: 37623967
[TBL] [Abstract][Full Text] [Related]
2. Peptide presentation on primate erythroparvovirus 1 virus-like particles: In vitro assembly, stability and immunological properties.
Del Carmen Morán-García A; Rivera-Toledo E; Echeverría O; Vázquez-Nin G; Gómez B; Bustos-Jaimes I
Virus Res; 2016 Sep; 224():12-8. PubMed ID: 27523978
[TBL] [Abstract][Full Text] [Related]
3. In vitro refolding of the structural protein VP1 of parvovirus B19 produces virus-like particles with functional VP1 unique region.
Soto-Valerio IA; Cayetano-Cruz M; Valadez-García J; Guadarrama P; Méndez C; Bustos-Jaimes I
Virology; 2022 May; 570():57-66. PubMed ID: 35367742
[TBL] [Abstract][Full Text] [Related]
4. On-column refolding and off-column assembly of parvovirus B19 virus-like particles from bacteria-expressed protein.
Sánchez-Moguel I; Coffeen CF; Bustos-Jaimes I
Appl Microbiol Biotechnol; 2024 Jan; 108(1):160. PubMed ID: 38252281
[TBL] [Abstract][Full Text] [Related]
5. Construction of protein-functionalized virus-like particles of parvovirus B19.
Bustos-Jaimes I; Soto-Román RA; Gutiérrez-Landa IA; Valadez-García J; Segovia-Trinidad CL
J Biotechnol; 2017 Dec; 263():55-63. PubMed ID: 28935566
[TBL] [Abstract][Full Text] [Related]
6. Peptide display on a surface loop of human parvovirus B19 VP2: Assembly and characterization of virus-like particles.
Santillán-Uribe JS; Valadez-García J; Morán-García Adel C; Santillán-Uribe HC; Bustos-Jaimes I
Virus Res; 2015 Apr; 201():1-7. PubMed ID: 25701743
[TBL] [Abstract][Full Text] [Related]
7. Tracking of Human Parvovirus B19 Virus-Like Particles Using Short Peptide Tags Reveals a Membrane-Associated Extracellular Release of These Particles.
Ishida K; Noguchi T; Kimura S; Suzuki H; Ebina H; Morita E
J Virol; 2023 Feb; 97(2):e0163122. PubMed ID: 36749078
[TBL] [Abstract][Full Text] [Related]
8. Human parvovirus B19 virus-like particles: In vitro assembly and stability.
Sánchez-Rodríguez SP; Münch-Anguiano L; Echeverría O; Vázquez-Nin G; Mora-Pale M; Dordick JS; Bustos-Jaimes I
Biochimie; 2012 Mar; 94(3):870-8. PubMed ID: 22192916
[TBL] [Abstract][Full Text] [Related]
9. Enhanced assembly and colloidal stabilization of primate erythroparvovirus 1 virus-like particles for improved surface engineering.
Sánchez-Rodríguez SP; Morán-García Adel C; Bolonduro O; Dordick JS; Bustos-Jaimes I
Acta Biomater; 2016 Apr; 35():206-14. PubMed ID: 26911883
[TBL] [Abstract][Full Text] [Related]
10. Stability and integrity of self-assembled bovine parvovirus virus‑like particles (BPV‑VLPs) of VP2 and combination of VP1VP2 assisted by baculovirus-insect cell expression: a potential logistical platform for vaccine deployment.
Wubshet AK; Li GX; Li Q; Dai JF; Ding YZ; Zhou L; Qu M; Wang Y; Ma Z; Werid GM; Abera BH; Kebede AT; Sun Y; Yin X; Liu Y; Jie Z
Virol J; 2024 Apr; 21(1):87. PubMed ID: 38641833
[TBL] [Abstract][Full Text] [Related]
11. Recombinant Virus-like Particles of Human Parvovirus B19 with the Internal Location of VP1 Unique Region Produced by
Shao S; Wang Q; Jin Y; Zhang X; Liu Z; Chen S; Wu H; Yang S; Tang F; Su J; Liang Y; Zhang J; Li Q
Viruses; 2022 Oct; 14(11):. PubMed ID: 36366508
[TBL] [Abstract][Full Text] [Related]
12. Construction of polyomavirus-derived pseudotype virus-like particles displaying a functionally active neutralizing antibody against hepatitis B virus surface antigen.
Pleckaityte M; Bremer CM; Gedvilaite A; Kucinskaite-Kodze I; Glebe D; Zvirbliene A
BMC Biotechnol; 2015 Sep; 15():85. PubMed ID: 26370129
[TBL] [Abstract][Full Text] [Related]
13. Purification and analysis of polyhistidine-tagged human parvovirus B19 VP1 and VP2 expressed in insect cells.
Michel PO; Mäkelä AR; Korhonen E; Toivola J; Hedman L; Söderlund-Venermo M; Hedman K; Oker-Blom C
J Virol Methods; 2008 Sep; 152(1-2):1-5. PubMed ID: 18598721
[TBL] [Abstract][Full Text] [Related]
14. Parvovirus B19 VP2-proteins produced in Saccharomyces cerevisiae: comparison with VP2-particles produced by baculovirus-derived vectors.
Lowin T; Raab U; Schroeder J; Franssila R; Modrow S
J Vet Med B Infect Dis Vet Public Health; 2005; 52(7-8):348-52. PubMed ID: 16316399
[TBL] [Abstract][Full Text] [Related]
15. In vitro encapsulation of heterologous dsDNA into human parvovirus B19 virus-like particles.
Sánchez-Rodríguez SP; Enrriquez-Avila JV; Soto-Fajardo JM; Peña-Montes C; Bustos-Jaimes I
Mol Biotechnol; 2015 Apr; 57(4):309-17. PubMed ID: 25389040
[TBL] [Abstract][Full Text] [Related]
16. Structural basis for the development of avian virus capsids that display influenza virus proteins and induce protective immunity.
Pascual E; Mata CP; Gómez-Blanco J; Moreno N; Bárcena J; Blanco E; Rodríguez-Frandsen A; Nieto A; Carrascosa JL; Castón JR
J Virol; 2015 Mar; 89(5):2563-74. PubMed ID: 25520499
[TBL] [Abstract][Full Text] [Related]
17. Assembly of fluorescent chimeric virus-like particles of canine parvovirus in insect cells.
Gilbert L; Toivola J; Lehtomäki E; Donaldson L; Käpylä P; Vuento M; Oker-Blom C
Biochem Biophys Res Commun; 2004 Jan; 313(4):878-87. PubMed ID: 14706624
[TBL] [Abstract][Full Text] [Related]
18. B19-VLPs as an effective delivery system for tumour antigens to induce humoral and cellular immune responses against triple negative breast cancer.
Jiménez-Chávez ÁJ; Nava-García BK; Bustos-Jaimes I; Moreno-Fierros L
Immunol Lett; 2021 Nov; 239():77-87. PubMed ID: 34508790
[TBL] [Abstract][Full Text] [Related]
19. Generation of a parvovirus B19 vaccine candidate.
Chandramouli S; Medina-Selby A; Coit D; Schaefer M; Spencer T; Brito LA; Zhang P; Otten G; Mandl CW; Mason PW; Dormitzer PR; Settembre EC
Vaccine; 2013 Aug; 31(37):3872-8. PubMed ID: 23827313
[TBL] [Abstract][Full Text] [Related]
20. Enhanced kinetic extraction of parvovirus B19 structural proteins.
Sico C; White S; Tsao E; Varma A
Biotechnol Bioeng; 2002 Nov; 80(3):250-6. PubMed ID: 12226856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
